Biomaterials for Treatments of Neurodegenerative Disorders

Yue Yu , Jiandong Ding

Engineering ›› : 202606006

PDF (4285KB)
Engineering ›› :202606006 DOI: 10.1016/j.eng.2026.06.006
research-article
Biomaterials for Treatments of Neurodegenerative Disorders
Author information +
History +
PDF (4285KB)

Abstract

The function of a biomaterial has been expected from simply providing a passive structural support to actively modulating biological responses covering many aspects including but not limited to treatments of neurodegenerative disorders. This article reviews the advances of various biomedical materials relevant to treatments of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis. These progressive diseases pose multifaceted challenges, including the limited regenerative capacity and the formidable blood–brain barrier (BBB). The review introduces the interdisciplinary progress of brain-targeted biomaterials, encompassing synthetic polymers, biologically derived carriers, and inorganic nanoparticles, with particular attention to their roles in overcoming BBB penetration and enabling precise drug delivery. In parallel, we discuss neuroprotective and regenerative biomaterials that promote extracellular matrix (ECM) remodeling, enhance neuronal survival, and guide neural regeneration. In addition, biomaterials are being integral to the next generation of brain–machine interfaces or brain–computer interfaces, where the materials are used to improve device biocompatibility and long-term stability. The review also covers advances in deep brain stimulation and implantable neuro-prostheses for functional restoration of neurodegenerative disorders. Finally, we propose perspectives: ① integration of stimuli-responsive materials with biological carriers for precise and targeted drug delivery; ② prioritization of material–tissue interactions to enhance the safety and functionality of neuro-devices; ③ biomimetic design of ECM-inspired materials with neuro-protective and regenerative capacities; ④ investigation of dynamic interfaces between brain tissue and external implants to improve long-term performance of medical devices; and ⑤ convergence of artificial intelligence, organ-on-chip platforms, and biomaterials to accelerate translational research.

Keywords

Biomaterial / Neurodegenerative disorder / Alzheimer’s disease / Parkinson’s disease / Blood–brain barrier / Brain–machine interface / Brain–computer interface / Polymer

Cite this article

Download citation ▾
Yue Yu, Jiandong Ding. Biomaterials for Treatments of Neurodegenerative Disorders. Engineering 202606006 DOI:10.1016/j.eng.2026.06.006

登录浏览全文

4963

注册一个新账户 忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within
[1]

Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov 2020; 19(9):609—33.
[2]

Tolosa E, Garrido A, Scholz SW, Poewe W . Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol 2021; 20(5):385-97.
[3]

Sweeney MD, Sagare AP, Zlokovic BV . Blood—brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 2018; 14(3):133-50.
[4]

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R . Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 2021; 20(2):101-24.
[5]

Cao D, Ding J . Recent advances in regenerative biomaterials. Regen Biomater 2022; 1:1182-218.
[6]

Wang H, Liu R, Yu Y, Xue H, Shen R, Zhang Y, et al. Effects of cell shape and nucleus shape on epithelial—mesenchymal transition revealed using chimeric micropatterns. Biomaterials 2025; 317:123013.
[7]

Harimoto T, Jung WH, Mooney D . Delivering living medicines with biomaterials. Nat Rev Mater 2025; 10(3):191-210.
[8]

Liu X, Zhang M, Wang P, Zheng K, Wang X, Xie W, et al. Nanoscale distribution of bioactive ligands on biomaterials regulates cell mechanosensing through translocation of actin into the nucleus. Proc Natl Acad Sci USA 2025; 122(10):e2501264122.
[9]

Wang G, Feng Y, Gao C, Zhang X, Wang Q, Zhang J, et al. Biaxial stretching of polytetrafluoroethylene in industrial scale to fabricate medical ePTFE membrane with node—fibril microstructure. Regen Biomater 2023; 10:rbad056.
[10]

Fu Y, Okuro K, Ding J, Aida T . Clay nanosheet—based nanocomposite supramolecular hydrogel enabling rapid, reversible phase transition only with visible light. Angew Chem Int Ed Engl 2025; 64(4):e202416541.
[11]

Duan N, Luo XR, Zhou YD, Chai JY, Wang JZ, Gao J, et al. Facile synthesis of an injectable redox/pH dual stimuli—responsive hydrogel system for drug release. Chin J Polym Sci 2026; 44(4):1114—25.
[12]

Yin S, Hou J, Li J, Zeng C, Chen S, Zhang H, et al. Polydopamine—modified black phosphorus nanosheet drug delivery system for the treatment of ischemic stroke. Regen Biomater 2024; 11:rbae046.
[13]

Saraiva C, Praça C, Ferreira R, Santos T, Ferreira L, Bernardino L . Nanoparticle—mediated brain drug delivery: overcoming blood—brain barrier to treat neurodegenerative diseases. J Control Release 2016; 235:34-47.
[14]

Furtado D, Björnmalm M, Ayton S, Bush AI, Kempe K, Caruso F . Overcoming the blood—brain barrier: the role of nanomaterials in treating neurological diseases. Adv Mater 2018; 30(46):e1801362.
[15]

Achar A, Myers R, Ghosh C . Drug delivery challenges in brain disorders across the blood—brain barrier: novel methods and future considerations for improved therapy. Biomedicines 2021; 9(12):1834.
[16]

Banks WA . From blood—brain barrier to blood—brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov 2016; 15(4):275-92.
[17]

Zhang JN, Ma YR, Yuan LTY, Jia S, Yu XM, Yuan Y, et al. A brief review on ultrasound induced drug activation systems. Chin J Polym Sci 2025; 43(11):1950—72.
[18]

Oller—Salvia B, Sánchez—Navarro M, Giralt E, Teixidó M . Blood—brain barrier shuttle peptides: an emerging paradigm for brain delivery. Chem Soc Rev 2016; 45(17):4690-707.
[19]

Cui S, Yu L, Ding J . Semi—bald micelles and corresponding percolated micelle networks of thermogels. Macromolecules 2018; 51(16):6405—20.
[20]

Narkar AR, Tong Z, Soman P, Henderson JH . Smart biomaterial platforms: controlling and being controlled by cells. Biomaterials 2022; 283:121450.
[21]

Gao XJ, Ciura K, Ma Y, Mikolajczyk A, Jagiello K, Wan Y, et al. Toward the integration of machine learning and molecular modeling for designing drug delivery nanocarriers. Adv Mater 2024; 36(45):e2407793.
[22]

Abramson A, Caffarel—Salvador E, Khang M, Dellal D, Silverstein D, Gao Y, et al. An ingestible self—orienting system for oral delivery of macromolecules. Science 2019; 363(6427):611-5.
[23]

Wang X, Lei X, Yu Y, Miao S, Tang J, Fu Y, et al. Biological sealing and integration of a fibrinogen—modified titanium alloy with soft and hard tissues in a rat model. Biomater Sci 2021; 9(15):5192-208.
[24]

Tadros AR, Romanyuk A, Miller IC, Santiago A, Noel RK, O’Farrell L, et al. STAR particles for enhanced topical drug and vaccine delivery. Nat Med 2020; 26(3):341-7.
[25]

Arrieta VA, Gould A, Kim KS, Habashy KJ, Dmello C, Vázquez—Cervantes GI, et al. Ultrasound—mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD—1 blockade in gliomas. Nat Commun 2024; 15(1):4698.
[26]

Liu W, Liu R, Chu LT, Wang X, Wu J, Ding J, et al. Y—shaped DNA as a dynamic self—assembly nanomaterial for phenotype—specific regulation of stem cell differentiation on the gene level. Regen Biomater 2025; 12:rbaf043.
[27]

Hubbell JA, Chilkoti A . Chemistry. Nanomaterials for drug delivery. Science 2012; 337(6092):303-5.
[28]

Duro—Castano A, Borrás C, Herranz—Pérez V, Blanco—Gandía MC, Conejos—Sánchez I, Armiñán A, et al. Targeting Alzheimer’s disease with multimodal polypeptide—based nanoconjugates. Sci Adv 2021; 7(13):eabf9180.
[29]

Zheng H, Zhang L, Bai X, Zhu J, Liu S, Ke Y, et al. GCN5—targeted dual—modal probe across the blood—brain barrier for borders display in invasive glioblastoma. Nat Commun 2025; 16(1):2345.
[30]

Han Q, Brenes D, Bishop KW, Pichon TJ, Ling M, McPheron GD, et al. Delivery of a fibrin—binding hemostatic polymer ameliorates neurovascular damage and neural tissue loss after traumatic brain injury. Sci Adv 2025; 11(29):eadw7425.
[31]

Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV . Establishment and dysfunction of the blood—brain barrier. Cell 2015; 163(5):1064-78.
[32]

Kadry H, Noorani B, Cucullo L . A blood—brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS 2020; 17(1):69.
[33]

Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y . The blood—brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther 2023; 8(1):217.
[34]

Hervé F, Ghinea N, Scherrmann JM . CNS delivery via adsorptive transcytosis. AAPS J 2008; 10(3):455-72.
[35]

López—Aguirre M, Castillo—Ortiz M, Viña—González A, Blesa J, Pineda—Pardo JA . The road ahead to successful BBB opening and drug—delivery with focused ultrasound. J Control Release 2024; 372:901-13.
[36]

Al Abdullah S, Najm L, Ladouceur L, Ebrahimi F, Shakeri A, Al—Jabouri N, et al. Functional nanomaterials for the diagnosis of Alzheimer’s disease: recent progress and future perspectives. Adv Funct Mater 2023; 33(37):2302673.
[37]

Zhang W, Mehta A, Tong Z, Esser L, Voelcker NH . Development of polymeric nanoparticles for blood—brain barrier transfer—strategies and challenges. Adv Sci 2021; 8(10):2003937.
[38]

Zhang Y, Wang X, Gu Q, Lu C, Zhao Y, Li X . Two—in—one: multifunctional poloxamer hydrogel accelerates endometrial regeneration and fertility restoration through synergistic regulation of KGF—2 and NO. Regen Biomater 2025; 12:rbaf062.
[39]

Wu Y, Feng H, Gao L, Wang X, Hu Y, He X, et al. Functionalized biomimetic nanoparticles are delivered from the nose to the brain for the synergistic targeted treatment of cerebral ischemia/reperfusion injury. Regen Biomater 2025; 12:rbaf063.
[40]

Zhao XM, Liu P . Synthesis of amphiphilic pH—responsive doxorubicin and ferrocene—containing copolyprodrug as drug self—delivery system and its in vitro synergistic apoptosis and ferroptosis tumor therapy. Chin J Polym Sci 2025; 43(5):730—7.
[41]

Teng Y, Song L, Shi J, Lv Q, Hou S, Ramakrishna S . Advancing electrospinning towards the future of biomaterials in biomedical engineering. Regen Biomater 2025; 12:rbaf034.
[42]

Yu L, Zhang H, Ding J . A subtle end—group effect on macroscopic physical gelation of triblock copolymer aqueous solutions. Angew Chem Int Ed 2006; 45(14):2232—5.
[43]

Cui S, Chen L, Yu L, Ding J . Synergism among polydispersed amphiphilic block copolymers leading to spontaneous physical hydrogelation upon heating. Macromolecules 2020; 53(18):7726—39.
[44]

Paunovska K, Loughrey D, Dahlman JE . Drug delivery systems for RNA therapeutics. Nat Rev Genet 2022; 23(5):265-80.
[45]

Dasgupta A, Sun T, Rama E, Motta A, Zhang Y, Power C, et al. Transferrin receptor—targeted nonspherical microbubbles for blood—brain barrier sonopermeation. Adv Mater 2023; 35(52):e2308150.
[46]

Zha S, Liu H, Li H, Li H, Wong KL, All AH . Functionalized nanomaterials capable of crossing the blood—brain barrier. ACS Nano 2024; 18(3):1820-45.
[47]

Romero—Ben E, Goswami U, Soto—Cruz J, Mansoori—Kermani A, Mishra D, Martin—Saldaña S, et al. Polymer—based nanocarriers to transport therapeutic biomacromolecules across the blood—brain barrier. Acta Biomater 2025; 196:17-49.
[48]

Guo C, Jiang X, Guo X, Liu Z, Wang B, Du Y, et al. Dual stimulus—responsive renewable nanoadsorbent for selective adsorption of low—density lipoprotein in serum. Regen Biomater 2024; 11:rbae045.
[49]

Herrmann IK, Wood MJA, Fuhrmann G . Extracellular vesicles as a next—generation drug delivery platform. Nat Nanotechnol 2021; 16(7):748-59.
[50]

Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 2015; 18(11):1584-93.
[51]

Budnik V, Ruiz—Cañada C, Wendler F . Extracellular vesicles round off communication in the nervous system. Nat Rev Neurosci 2016; 17(3):160-72.
[52]

Kojima R, Bojar D, Rizzi G, Hamri GCE, El—Baba MD, Saxena P, et al. Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment. Nat Commun 2018; 9(1):1305.
[53]

Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, et al. Large—scale generation of functional mRNA—encapsulating exosomes via cellular nanoporation. Nat Biomed Eng 2020; 4(1):69-83.
[54]

Wang J, Tang W, Yang M, Yin Y, Li H, Hu F, et al. Inflammatory tumor microenvironment responsive neutrophil exosomes—based drug delivery system for targeted glioma therapy. Biomaterials 2021; 273:120784.
[55]

Nguyen TTK, Pham KY, Yook S . Engineered therapeutic proteins for sustained—release drug delivery systems. Acta Biomater 2023; 171:131-54.
[56]

Du S, Guan Y, Xie A, Yan Z, Gao S, Li W, et al. Extracellular vesicles: a rising star for therapeutics and drug delivery. J Nanobiotechnology 2023; 21(1):231.
[57]

Li J, Ni W, Jin D, Yu Y, Xiao MM, Zhang ZY, et al. Nanosensor—driven detection of neuron—derived exosomal a b42 with graphene electrolyte—gated transistor for Alzheimer’s disease diagnosis. Anal Chem 2023; 95(13):5719—28.
[58]

Wang Q, Li T, Yang J, Zhao Z, Tan K, Tang S, et al. Engineered exosomes with independent module/cascading function for therapy of parkinson’s disease by multistep targeting and multistage intervention method. Adv Mater 2022; 34(27):e2201406.
[59]

Liu L, Li Y, Peng H, Liu R, Ji W, Shi Z, et al. Targeted exosome coating gene—chem nanocomplex as ‘‘nanoscavenger” for clearing a—synuclein and immune activation of Parkinson’s disease. Sci Adv 2020; 6(50):eaba3967.
[60]

Zhao P, Wang J, Huang H, Chen Z, Wang H, Lin Q . Exosomes—based dual drug—loaded nanocarrier for targeted and multiple proliferative vitreoretinopathy therapy. Regen Biomater 2024; 11:rbae081.
[61]

Chen M, Wang S, Chen Y, Shen H, Chen L, Ding L, et al. Precision cardiac targeting: empowering curcumin therapy through smart exosome—mediated drug delivery in myocardial infarction. Regen Biomater 2024; 11:rbad108.
[62]

Li M, Fu S, Cai Z, Li D, Liu L, Deng D, et al. Dual regulation of osteoclastogenesis and osteogenesis for osteoporosis therapy by iron oxide hydroxyapatite core/shell nanocomposites. Regen Biomater 2021; 8(5):rbab027.
[63]

Knipe JM, Peppas NA . Multi—responsive hydrogels for drug delivery and tissue engineering applications. Regen Biomater 2014;1(1):57-65.
[64]

Shen Y, Zhang W, Xie Y, Li A, Wang X, Chen X, et al. Surface modification to enhance cell migration on biomaterials and its combination with 3D structural design of occluders to improve interventional treatment of heart diseases. Biomaterials 2021; 279:121208.
[65]

Lee D, Park D, Kim I, Lee SW, Lee W, Hwang KS, et al. Plasmonic nanoparticle amyloid corona for screening Ab oligomeric aggregate—degrading drugs. Nat Commun 2021; 12(1):639.
[66]

Retout M, Amer L, Yim W, Creyer MN, Lam B, Trujillo DF, et al. A protease—responsive polymer/peptide conjugate and reversible assembly of silver clusters for the detection of Porphyromonas gingivalis enzymatic activity. ACS Nano 2023;17(17):308-19.
[67]

Rajpoot K. Nanotechnology—based targeting of neurodegenerative disorders: a promising tool for efficient delivery of neuromedicines. Curr Drug Targets 2020; 21(8):819-36.
[68]

De Vitis E, Stanzione A, Romano A, Quattrini A, Gigli G, Moroni L, et al. The evolution of technology—driven in vitro models for neurodegenerative diseases. Adv Sci 2024; 11(16):e2304989.
[69]

Amartumur S, Nguyen H, Huynh T, Kim TS, Woo RS, Oh E, et al. Neuropathogenesis—on—chips for neurodegenerative diseases. Nat Commun 2024; 15(1):2219.
[70]

Obeng E, Shen B, Wang W, Xie Z, Zhang W, Li Z, et al. Engineered biofunctional material—based nerve guide conduits for optic nerve regeneration: a view from the cellular perspective, challenges and the future outlook. Regen Biomater 2024; 12:rbae133.
[71]

Mullis AS, Kaplan DL . Functional bioengineered tissue models of neurodegenerative diseases. Biomaterials 2023; 298:122143.
[72]

Shao Y, Wang J, Jin A, Jiang S, Lei L, Liu L . Biomaterial—assisted organoid technology for disease modeling and drug screening. Mater Today Bio 2025; 30:30101438.
[73]

Wong CH, Siah KW, Lo AW . Estimation of clinical trial success rates and related parameters. Biostatistics 2019; 20(2):273-86.
[74]

Dowden H, Munro J . Trends in clinical success rates and therapeutic focus. Nat Rev Drug Discov 2019; 18(7):495-6.
[75]

Orloff J, Douglas F, Pinheiro J, Levinson S, Branson M, Chaturvedi P, et al. The future of drug development: advancing clinical trial design. Nat Rev Drug Discov 2009; 8(12):949-57.
[76]

Tarif E, Rahaman P, Roymahapatra G, Bag A . In—silico evaluation of novel donepezil analogues for Alzheimer’s disease: molecular docking and ADME profiling for potent human acetylcholinesterase (hAChE) inhibition. ES General 2025; 9:1748.
[77]

Wang YT, Shang LR, Zhao YJ, Sun LY . Microfluidic generation of multicomponent soft biomaterials. Engineering 2022; 13:128-43.
[78]

Loewa A, Feng JJ, Hedtrich S . Human disease models in drug development. Nat Rev Bioeng 2023:1-15.
[79]

Chai W, Chen X, Liu J, Zhang L, Liu C, Li L, et al. Recent progress in functional metal—organic frameworks for bio—medical application. Regen Biomater 2024; 11:rbad115.
[80]

Yin B, Fan Y, Li J, Li C, Jiang S, Li X, et al. ROS—triggered hydrophilicity switching synergizes with pH—responsive nanocarriers for therapy of diabetic wound. Regen Biomater 2025; 12:rbaf098.
[81]

Gao Y, Zhang Z, Yao Y, Zhang J, Li X, Yang K, et al. Engineering of tissue in microphysiological systems demonstrated by modelling skeletal muscle. Regen Biomater 2025; 12:rbaf059.
[82]

Yu Y, Xue H, Wang H, Fu Y, Zhang Y, Yu W, et al. A biomaterial—cell model of inflammation—induced neurodegeneration of Parkinson’s disease. Cell Biomaterials 2026; 2:100298.
[83]

Park J, Wetzel I, Marriott I, Dréau D, D’Avanzo C, Kim DY, et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease. Nat Neurosci 2018; 21(7):941-51.
[84]

Zhang M, Wang P, Wu Y, Jin L, Liu J, Deng P, et al. A microengineered 3D human neurovascular unit model to probe the neuropathogenesis of herpes simplex encephalitis. Nat Commun 2025; 16(1):3701.
[85]

Chen C, Hui J, Tian T, Jin L, Li X, Lin B, et al. Biomimetic bone—vessel interface—on—a—chip for simulating periodontal physiological and pathological microenvironment. Regen Biomater 2025; 12:rbaf111.
[86]

Aazmi A, Zhou HZ, Li YT, Yu MF, Xu XB, Wu YT, et al. Engineered vasculature for organ—on—a—chip systems. Engineering 2022; 9:131-47.
[87]

Wang J, Shao CM, Wang YT, Sun LY, Zhao YJ . Microfluidics for medical additive manufacturing. Engineering 2020; 6(11):1244-57.
[88]

Zhang T, Hong B, Liang Y . Microfluidic approaches in extracellular vesicle engineering: recent advances for enhanced therapeutic efficacy. Eng Sci 2026; 39:2013.
[89]

Qiao D, Li HX, Zhang X, Chen XH, Zhang J, Zou JN, et al. The convergence of artificial intelligence and microfluidics in drug research and development. Engineering 2025; 55:125-74.
[90]

Mou X, Li L, Liu XY, Zhang AL, He T, Rao BF, et al. Single—nucleus RNA sequencing reveals the mechanism of neonatal hypoxic—ischemic encephalopathy and the neuroprotection effects of salvianolic acid c. Engineering 2025; 55:269-90.
[91]

Wu H, Feng E, Yin H, Zhang Y, Chen G, Zhu B, et al. Biomaterials for neuroengineering: applications and challenges. Regen Biomater 2025; 12:rbae137.
[92]

Zhao J, Chen Y, Gao B, Zhang L, Gao N, Hao S, et al. Optogenetic engineering of synthetic and natural receptors: design principles, functional mechanisms and biomedical applications. Regen Biomater 2025; 13:rbaf126.
[93]

Huang RL, Yang J, Yan YX, Liu XQ, Yin XY, Liu CQ, et al. Direct differentiation of human adult adipose tissue into multilineage functional organoids. Engineering 2025; 53:286-300.
[94]

Farag VE, Devey EA, Leong KW . The interface of gene editing with regenerative medicine. Engineering 2025; 46:73-100.
[95]

Huang Y, Zhang X, Zhang W, Tang J, Liu J . Rational design matrix materials for organoid development and application in biomedicine. Regen Biomater 2025; 12:rbaf038.
[96]

Wang X, Xu T, Niu C . Vascularization ability of glioma stem cells in different three—dimensional microenvironments. Regen Biomater 2024; 11:rbad094.
[97]

Wang P, Qian LP, Liang HX, Huang JH, Jin J, Xie CM, et al. A polyvinyl alcohol/acrylamide hydrogel with enhanced mechanical properties promotes full—thickness skin defect healing by regulating immunomodulation and angiogenesis through paracrine secretion. Engineering 2024; 37:138-51.
[98]

Rosh I, Tripathi U, Hussein Y, Rike WA, Djamus J, Shklyar B, et al. Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K—GBA1 Parkinson’s disease patients. NPJ Parkinsons Dis 2024; 10(1):38.
[99]

Lou J, Mooney DJ . Chemical strategies to engineer hydrogels for cell culture. Nat Rev Chem 2022; 6(10):726-44.
[100]

Wei J, Sun Y, Wang H, Zhu T, Li L, Zhou Y, et al. Designer cellular spheroids with DNA origami for drug screening. Sci Adv 2024; 10(29):eado9880.
[101]

Sood D, Tang—Schomer M, Pouli D, Mizzoni C, Raia N, Tai A, et al. 3D extracellular matrix microenvironment in bioengineered tissue models of primary pediatric and adult brain tumors. Nat Commun 2019; 10(1):4529.
[102]

Zhuang RZ, Chesnais F, Vunjak—Novakovic G . Integrating hierarchical vasculature into engineered cardiac tissues. Adv Mater 2025; 37(47):e09242.
[103]

Álvarez Z, Ortega J, Sato K, Sasselli I, Kolberg—Edelbrock A, Qiu R, et al. Artificial extracellular matrix scaffolds of mobile molecules enhance maturation of human stem cell—derived neurons. Cell Stem Cell 2023; 30(2):219-38.
[104]

Han Y, Guo L, Wang M, Cao Z, Zheng X, Wang X, et al. Bioengineering an improved three—dimensional vascularized co—culture model for studying neuron—microglia interactions. Bioact Mater 2025; 54:813-28.
[105]

Liu X, Zhang G, Wei P, Zhong L, Chen Y, Zhang J, et al. Three—dimensional—printed collagen/chitosan/secretome derived from HUCMSCs scaffolds for efficient neural network reconstruction in canines with traumatic brain injury. Regen Biomater 2022; 9:rbac043.
[106]

Loukelis K, Koutsomarkos N, Mikos AG, Chatzinikolaidou M . Advances in 3D bioprinting for regenerative medicine applications. Regen Biomater 2024; 11:rbae033.
[107]

Zhang B, Gao L, Ma L, Luo YC, Yang HY, Cui Z . 3D bioprinting: a novel avenue for manufacturing tissues and organs. Engineering 2019; 5(4):777—94.
[108]

Zheng ZZ, Eglin D, Alini M, Richards GR, Qin L, Lai Y . Visible light—induced 3D bioprinting technologies and corresponding bioink materials for tissue engineering: a review. Engineering 2021;7(7):966—78.
[109]

Budharaju H, Singh RK, Kim HW . Bioprinting for drug screening: a path toward reducing animal testing or redefining preclinical research? Bioact Mater 2025; 51:993-1017.
[110]

Xu H, Zhang S, Song K, Yang H, Yin J, Huang Y . Droplet—based 3D bioprinting for drug delivery and screening. Adv Drug Deliv Rev 2025; 217:115486.
[111]

Shukla P, Bera AK, Ghosh A, Kiranmai G, Pati F . Assessment and process optimization of high throughput biofabrication of immunocompetent breast cancer model for drug screening applications. Biofabrication 2024; 16(3):3.
[112]

Cardoso BD, Castanheira EMS, Lanceros—Méndez S, Cardoso VF . Recent advances on cell culture platforms for in vitro drug screening and cell therapies: from conventional to microfluidic strategies. Adv Healthc Mater 2023; 12(18):e2202936.
[113]

Means JC, Martinez—Bengochea AL, Louiselle DA, Nemechek JM, Perry JM, Farrow EG, et al. Rapid and scalable personalized ASO screening in patient—derived organoids. Nature 2025; 638(8049):237-43.
[114]

Liu X, Mao Y, Huang S, Li W, Zhang W, An J, et al. Selenium nanoparticles derived from Proteus mirabilis YC801 alleviate oxidative stress and inflammatory response to promote nerve repair in rats with spinal cord injury. Regen Biomater 2022; 9:rbac042.
[115]

Zhang H, Qin C, Shi Z, Xue J, Hao J, Huang J, et al. Bioprinting of inorganic—biomaterial/neural—stem—cell constructs for multiple tissue regeneration and functional recovery. Natl Sci Rev 2024; 11(4):nwae035.
[116]

Gage FH, Temple S . Neural stem cells: generating and regenerating the brain. Neuron 2013; 80(3):588-601.
[117]

Barker RA, Götz M, Parmar M . New approaches for brain repair—from rescue to reprogramming. Nature 2018; 557(7705):329-34.
[118]

Götz M, Torres—Padilla ME . Stem cells as role models for reprogramming and repair. Science 2025; 388(6746):eadp2959.
[119]

Yao X, Yan Z, Wang X, Jiang H, Qian Y, Fan C . The influence of reduced graphene oxide on stem cells: a perspective in peripheral nerve regeneration. Regen Biomater 2021; 8(4):rbab032.
[120]

Rizzo F, Kehr NS . Recent advances in injectable hydrogels for controlled and local drug delivery. Adv Healthc Mater 2021; 10(1):e2001341.
[121]

Wei Y, Cui S, Yu L, Ding J . Degradation—influenced/induced self—assembly of copolymers with the combinatory effects of changed molecular weight and dispersity. Macromolecules 2023; 56(7):2619-36.
[122]

Wang Y, Zoneff ER, Thomas JW, Hong N, Tan LL, McGillivray DJ, et al. Hydrogel oxygen reservoirs increase functional integration of neural stem cell grafts by meeting metabolic demands. Nat Commun 2023; 14(1):457.
[123]

Zhang L, Yin JC, Yeh H, Ma NX, Lee G, Chen XA, et al. Small molecules efficiently reprogram human astroglial cells into functional neurons. Cell Stem Cell 2015; 17(6):735-47.
[124]

Liu P, Zhang T, Wu Y, Chen Q, Sun T, Jiang C . A peptide—drug conjugate—based nanoplatform for immunometabolic activation and in situ nerve regeneration in advanced—stage Alzheimer’s disease. Adv Mater 2024; 36(46):e2408729.
[125]

Rahimi Darehbagh R, Seyedoshohadaei SA, Ramezani R, Rezaei N . Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives. Eur J Med Res 2024; 29(1):386.
[126]

Tang J, Peng R, Ding J . The regulation of stem cell differentiation by cell—cell contact on micropatterned material surfaces. Biomaterials 2010; 31(9):2470—6.
[127]

Peng Y, Liu QJ, He T, Ye K, Yao X, Ding J . Degradation rate affords a dynamic cue to regulate stem cells beyond varied matrix stiffness. Biomaterials 2018; 178:467—80.
[128]

Gao CY, Wang G, Wang L, Wang QS, Wang HC, Yu L, et al. A biosurfactant—containing TSD strategy to modify bovine pericardial bioprosthetic valves for anticalcification. Chin J Polym Sci 2023; 41(1):51-66.
[129]

Bektas CK, Luo J, Conley B, Le KN, Lee KB . 3D bioprinting approaches for enhancing stem cell—based neural tissue regeneration. Acta Biomater 2025; 193:20-48.
[130]

Tian L, Prabhakaran MP, Ramakrishna S . Strategies for regeneration of components of nervous system: scaffolds, cells and biomolecules. Regen Biomater 2015; 2(1):31-45.
[131]

Degterev A, Yuan J . Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 2008; 9(5):378—90.
[132]

Hickman S, Izzy S, Sen P, Morsett L, El Khoury J . Microglia in neurodegeneration. Nat Neurosci 2018; 21(10):1359-69.
[133]

Ye K, Wang X, Cao L, Li S, Li Z, Yu L, et al. Matrix stiffness and nanoscale spatial organization of cell—adhesive ligands direct stem cell fate. Nano Lett 2015; 15(7):4720—9.
[134]

He J, Liu Q, Zheng S, Shen R, Wang X, Gao J, et al. Enlargement, reduction, and even reversal of relative migration speeds of endothelial and smooth muscle cells on biomaterials simply by adjusting RGD nanospacing. ACS Appl Mater Interfaces 2021; 13(36):42344—56.
[135]

Wang S, Zhu C, Zhang B, Hu J, Xu J, Xue C, et al. BMSC—derived extracellular matrix better optimizes the microenvironment to support nerve regeneration. Biomaterials 2022; 280:121251.
[136]

Gao JM, Yu XY, Wang XL, He YN, Ding JD . Biomaterial—related cell microenvironment in tissue engineering and regenerative medicine. Engineering 2022; 13:1331—45.
[137]

Park J, Jeon J, Kim B, Lee MS, Park S, Lim J, et al. Electrically conductive hydrogel nerve guidance conduits for peripheral nerve regeneration. Adv Funct Mater 2020; 30(39):202003759.
[138]

Liu Q, Zheng S, Ye K, He J, Shen Y, Cui S, et al. Cell migration regulated by RGD nanospacing and enhanced under moderate cell adhesion on biomaterials. Biomaterials 2020; 263:120327.
[139]

Yuan T, Shao Y, Zhou X, Liu Q, Zhu Z, Zhou B, et al. Highly permeable DNA supramolecular hydrogel promotes neurogenesis and functional recovery after completely transected spinal cord injury. Adv Mater 2021; 33(35):e2102428.
[140]

Zhao Y, Song S, Ren X, Zhang J, Lin Q, Zhao Y . Supramolecular adhesive hydrogels for tissue engineering applications. Chem Rev 2022; 122(6):5604—40.
[141]

Nain A, Chakraborty S, Barman SR, Gavit P, Indrakumar S, Agrawal A, et al. Progress in the development of piezoelectric biomaterials for tissue remodeling. Biomaterials 2024; 307:122528.
[142]

Xu C, Wu P, Yang K, Mu C, Li B, Li X, et al. Multifunctional biodegradable conductive hydrogel regulating microenvironment for stem cell therapy enhances the nerve tissue repair. Small 2024; 20(23):e2309793.
[143]

Zhang H, Guo JH, Wang Y, Shang LR, Chai RJ, Zhao YJ . Natural polymer—derived bioscaffolds for peripheral nerve regeneration. Adv Funct Mater 2022; 32(41):202203829.
[144]

Ligorio C, Mata A . Synthetic extracellular matrices with function—encoding peptides. Nat Rev Bioeng 2023;1(7):1-19.
[145]

Xie C, Chen Y, Wang L, Liao K, Xue B, Han Y, et al. Recent research of peptide—based hydrogel in nervous regeneration. Bioact Mater 2024; 40:503-23.
[146]

Adak A, Das G, Barman S, Mohapatra S, Bhunia D, Jana B, et al. Biodegradable neuro—compatible peptide hydrogel promotes neurite outgrowth, shows significant neuroprotection, and delivers anti—Alzheimer drug. ACS Appl Mater Interfaces 2017; 9(6):5067-76.
[147]

Piotrowicz A, Shoichet MS . Nerve guidance channels as drug delivery vehicles. Biomaterials 2006; 27(9):2018— 27.
[148]

Yan Y, Yao R, Zhao J, Chen K, Duan L, Wang T, et al. Implantable nerve guidance conduits: material combinations, multi—functional strategies and advanced engineering innovations. Bioact Mater 2022; 11:1157-76.
[149]

Wang Y, Liu F, Shan Q, Wang X, Liu W, Chen X, et al. Functional recovery induced by KCC2—enabled relay pathways in completely injured spinal cords in adult rats. Proc Natl Acad Sci USA 2025; 122(50):e2421823122.
[150]

Carvalho CR, Chang W, Silva—Correia J, Reis RL, Oliveira JM, Kohn J . Engineering silk fibroin—based nerve conduit with neurotrophic factors for proximal protection after peripheral nerve injury. Adv Healthc Mater 2021; 10(2):e2000753.
[151]

Manoukian OS, Rudraiah S, Arul MR, Bartley JM, Baker JT, Yu X, et al. Biopolymer—nanotube nerve guidance conduit drug delivery for peripheral nerve regeneration: in vivo structural and functional assessment. Bioact Mater 2021; 6(9):2881-93.
[152]

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4):663-76.
[153]

Chen J, Cheng X, Yu Z, Deng R, Cui R, Zhou J, et al. Sustained delivery of NT—3 and curcumin augments microenvironment modulation effects of decellularized spinal cord matrix hydrogel for spinal cord injury repair. Regen Biomater 2024; 11:rbae039.
[154]

Hao F, Jia F, Hao P, Duan H, Wang Z, Fan Y, et al. Proper wiring of newborn neurons to control bladder function after complete spinal cord injury. Biomaterials 2023; 292:121919.
[155]

Lai C, Hou K, Li W, Wang J, Cai X, Shi Y, et al. Olig2 acts as an inducible barrier to in vivo astrocyte—to—neuron conversion. Nat Commun 2026; 17(1):2033.
[156]

Ransohoff RM . How neuroinflammation contributes to neurodegeneration. Science 2016; 353(6301):777-83.
[157]

Mukherjee S, Madamsetty V, Bhattacharya D, Chowdhury SR, Paul M, Mukherjee A . Recent advancements of nanomedicine in neurodegenerative disorders theranostics. Adv Funct Mater 2020; 30:202003054.
[158]

Galindo AN, Frey Rubio DA, Hettiaratchi MH . Biomaterial strategies for regulating the neuroinflammatory response. Mater Adv 2024; 5(10):4025-54.
[159]

Athauda D, Foltynie T . The ongoing pursuit of neuroprotective therapies in Parkinson disease. Nat Rev Neurol 2015; 11(1):25-40.
[160]

Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson’s disease and its potential as therapeutic target. Transl Neurodegener 2015;4(1):19.
[161]

Azzini E, Peña—Corona SI, Hernández—Parra H, Chandran D, Saleena LAK, Sawikr Y, et al. Neuroprotective and anti—inflammatory effects of curcumin in Alzheimer’s disease: targeting neuroinflammation strategies. Phytother Res 2024; 38(6):3169—89.
[162]

Wilson DM, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I . Hallmarks of neurodegenerative diseases. Cell 2023; 186(4):693-714.
[163]

Gao HM, Hong JS . Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 2008; 29(8):357-65.
[164]

Gulen MF, Samson N, Keller A, Schwabenland M, Liu C, Glück S, et al. cGAS—STING drives ageing—related inflammation and neurodegeneration. Nature 2023; 620(7973):374-80.
[165]

Harris JP, Burrell JC, Struzyna LA, Chen HI, Serruya MD, Wolf JA, et al. Emerging regenerative medicine and tissue engineering strategies for Parkinson’s disease. NPJ Parkinsons Dis 2020; 6(1):4.
[166]

Liu X, Liu R, Cao B, Ye K, Li S, Gu Y, et al. Subcellular cell geometry on micropillars regulates stem cell differentiation. Biomaterials 2016; 111:27-39.
[167]

Sonvico F, Clementino A, Buttini F, Colombo G, Pescina S, Stanisçuaski Guterres S, et al. Surface—modified nanocarriers for nose—to—brain delivery: from bioadhesion to targeting. Pharmaceutics 2018; 10(1):34.
[168]

Li X, Ding J . Establishment of coverage—mass equation to quantify the corrosion inhomogeneity and examination of medium effects on iron corrosion. Regen Biomater 2023; 10:rbad007.
[169]

Gandhi S, Shastri DH, Shah J, Nair AB, Jacob S . Nasal delivery to the brain: harnessing nanoparticles for effective drug transport. Pharmaceutics 2024; 16(4):481.
[170]

Huang J, Grater SV, Corbellini F, Rinck S, Bock E, Kemkemer R, et al. Impact of order and disorder in RGD nanopatterns on cell adhesion. Nano Lett 2009; 9(3):1111-6.
[171]

Bellis SL . Advantages of RGD peptides for directing cell association with biomaterials. Biomaterials 2011; 32(18):4205—10.
[172]

He J, Shen R, Liu Q, Zheng S, Wang X, Gao J, et al. RGD nanoarrays with nanospacing gradient selectively induce orientation and directed migration of endothelial and smooth muscle cells. ACS Appl Mater Interfaces 2022; 14(33):37436—46.
[173]

Cho Y, Choi Y, Seong H . Nanoscale surface coatings and topographies for neural interfaces. Acta Biomater 2024; 175:55-75.
[174]

Huang N, Huang W, Wang M, Shi J, Luo Y, Huang J . Biomaterials in alzheimer’s disease: an anti—neuroinflammatory perspective. Adv Healthc Mater 2025; 14(19):e2500498.
[175]

Mukherjee S, Madamsetty VS, Bhattacharya D, Chowdhury SR, Paul MK, Mukherjee A . Recent advancements of nanomedicine in neurodegenerative disorders theranostics. Adv Funct Mater 2020; 30(35):2003054.
[176]

Han X, Li B, Wang W, Feng B, Tang Q, Qi Y, et al. Cerium vanadate nanozyme with pH—dependent dual enzymatic activity for glioblastoma targeted therapy and postradiotherapy damage protection. ACS Nano 2024; 18(30):19836-53.
[177]

Gao J, Xu X, Yu X, Fu Y, Zhang H, Gu S, et al. Quantitatively relating magnetic resonance T1 and T2 to glycosaminoglycan and collagen concentrations mediated by penetrated contrast agents and biomacromolecule—bound water. Regen Biomater 2023; 10:rbad035.
[178]

Eckman N, Nejatfard A, Cavet R, Grosskopf A, Appel E . Biomaterials to enhance adoptive cell therapy. Nat Rev Bioeng 2024; 2(5):408-24.
[179]

Zhang H, Li X, Qu Z, Zhang W, Wang Q, Cao D, et al. Effects of serum proteins on corrosion rates and product bioabsorbability of biodegradable metals. Regen Biomater 2024; 11:rbad112.
[180]

Pearce H, Kim YS, Diaz—Gomez L, Mikos A . Tissue engineering scaffolds. In: Wagner WR, Sakiyama—Elbert SE, Zhang G, Yaszemski MJ, editors. Biomaterials science. Cambridge, MA: Academic Press; 2020. p. 1317—34.
[181]

Shi D, Kang Y, Wang W, Liu R, Tang Q, Li Z, et al. Biodegradable polymeric occluder with controllable locking structure for closure of atrial septal defect via interventional treatment. Regen Biomater 2025; 12:rbaf016.
[182]

Wang X, Sun X, Gan D, Soubrier M, Chiang HY, Yan L, et al. Bioadhesive and conductive hydrogel—integrated brain—machine interfaces for conformal and immune—evasive contact with brain tissue. Matter 2022; 5(4):1204-23.
[183]

Cai XX, Xu ZJ, Liu JQ, Wang RB, Wu YR . Recent advances in intracortical neural interfaces for freely moving animals: technologies and applications. Engineering 2025; 44:4473—86.
[184]

Lebedev MA, Nicolelis MAL . Brain—machine interfaces: past, present and future. Trends Neurosci 2006; 29(9):536—46.
[185]

Lebedev MA, Nicolelis MAL . Brain—machine interfaces: from basic science to neuroprostheses and neurorehabilitation. Physiol Rev 2017; 97(2):767-837.
[186]

Hettick M, Ho E, Poole AJ, Monge M, Papageorgiou D, Takahashi K, et al. Minimally invasive implantation of scalable high—density cortical microelectrode arrays for multimodal neural decoding and stimulation. Nat Biomed Eng 2025.
[187]

Fan J, Fang L, Wu J, Guo Y, Dai Q . From brain science to artificial intelligence. Engineering 2020; 6(3):248-52.
[188]

Palmer C. Brain—computer interface speaks up. Engineering 2022; 9:3-5.
[189]

Bennett C, Mohammed F, Álvarez—Ciara A, Nguyen MA, Dietrich WD, Rajguru SM, et al. Neuroinflammation, oxidative stress, and blood—brain barrier (BBB) disruption in acute Utah electrode array implants and the effect of deferoxamine as an iron chelator on acute foreign body response. Biomaterials 2019; 188:144-59.
[190]

Zeng Q, Huang Z . Challenges and opportunities of implantable neural interfaces: from material, electrochemical and biological perspectives. Adv Funct Mater 2023;33(32):33.
[191]

Filippova A, Bonini F, Efremova L, Locatelli M, Preynat—Seauve O, Béduer A, et al. Neurothreads: development of supportive carriers for mature dopaminergic neuron differentiation and implantation. Biomaterials 2021; 270:120707.
[192]

Yu Y, Wang X, Zhu Y, He Y, Xue H, Ding J . Is polydopamine beneficial for cells on the modified surface? Regen Biomater 2022; 9:rbac078.
[193]

Gilron R, Little S, Perrone R, Wilt R, de Hemptinne C, Yaroshinsky MS, et al. Long—term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson’s disease. Nat Biotechnol 2021; 39(9):1078-85.
[194]

Xu MP, He F, Jung P, Gu XS, Ming D . Current challenges for the practical application of electroencephalography—based brain—computer interfaces. Engineering 2021; 7(12):1710—2.
[195]

Aziz T, Tass P, Hariz M, Horn A, Brown P, Lozano A, et al. Technology of deep brain stimulation: current status and future directions. Nat Rev Neurol 2020; 17(2):75-87.
[196]

Rajamani N, Friedrich H, Butenko K, Dembek T, Lange F, Navratil P, et al. Deep brain stimulation of symptom—specific networks in Parkinson’s disease. Nat Commun 2024; 15:4662.
[197]

Cagnan H, McIntyre C, Brown P, Denison T . Emerging technologies for improved deep brain stimulation. Nat Biotechnol 2019; 37(9):1024—33.
[198]

Violante IR, Alania K, Cassarà AM, Neufeld E, Acerbo E, Carron R, et al. Non—invasive temporal interference electrical stimulation of the human hippocampus. Nat Neurosci 2023; 26(11):1994-2004.
[199]

Kim T, Kim HJ, Choi W, Lee YM, Pyo JH, Lee J, et al. Deep brain stimulation by blood—brain—barrier—crossing piezoelectric nanoparticles generating current and nitric oxide under focused ultrasound. Nat Biomed Eng 2023; 7(2):149-63.
[200]

Boutet A, Madhavan R, Elias GJB, Joel SE, Gramer R, Ranjan M, et al. Predicting optimal deep brain stimulation parameters for Parkinson’s disease using functional MRI and machine learning. Nat Commun 2021; 12(1):3043.
[201]

Wang J, Wang T, Liu H, Wang K, Moses K, Feng Z, et al. Flexible electrodes for brain—computer interface system. Adv Mater 2023; 35(47):e2211012.
[202]

Fan X, Nie W, Tsai H, Wang N, Huang H, Cheng Y, et al. PEDOT:PSS for flexible and stretchable electronics: modifications, strategies, and applications. Adv Sci 2019; 6:201900813.
[203]

Kang H, Jung S, Jeong S, Kim G, Lee K . Polymer—metal hybrid transparent electrodes for flexible electronics. Nat Commun 2015; 6(1):6503.
[204]

McGlynn E, Nabaei V, Ren E, Galeote—Checa G, Das R, Curia G, et al. The future of neuroscience: flexible and wireless implantable neural electronics. Adv Sci 2021; 8(10):2002693.
[205]

Lozano AM, Lipsman N, Bergman H, Brown P, Chabardes S, Chang JW, et al. Deep brain stimulation: current challenges and future directions. Nat Rev Neurol 2019; 15(3):148-60.
[206]

Cho Y, Park S, Lee J, Yu KJ . Emerging materials and technologies with applications in flexible neural implants: a comprehensive review of current issues with neural devices. Adv Materi 2021; 33(47):202005786.
[207]

Corsi M, Bellotti E, Surdo S, Barillaro G . Implantable bioresorbable electronic systems for sustainable precision medicine. Nat Rev Electr Eng 2025; 2(8):572-83.
[208]

Jang J, Jin S, Yoon S, Shin M, Son D . Materials strategy and device fabrication for stable closed—loop bioelectronics. NPJ Biosensing 2025; 2(1):27.
[209]

Shen R, Zhang Z, Li J, Ding J . Nonmonotonic dependence of random migration upon density of cells on biomaterials. ACS Appl Mater Interfaces 2026; 18(8):12480-93.
[210]

Rahmati M, Silva EA, Reseland JE, Heyward C, Haugen HJ . Biological responses to physicochemical properties of biomaterial surface. Chem Soc Rev 2020; 49(15):5178-224.
[211]

Chen A, Chen D, Lv K, Li G, Pan J, Ma D, et al. Zwitterionic polymer/polydopamine coating of electrode arrays reduces fibrosis and residual hearing loss after cochlear implantation. Adv Healthc Mater 2023; 12(1):e2200807.
[212]

Bensmaia SJ, Miller LE . Restoring sensorimotor function through intracortical interfaces: progress and looming challenges. Nat Rev Neurosci 2014; 15(5):313-25.
[213]

III — biomaterial types. In: Williams D, Zhang X, editors. Definitions of biomaterials for the twenty—first century. Elsevier; 2019. p. 25-54.
[214]

IV — biocompatibility and immune responses to biomaterials. In: Williams D, Zhang X, editors. Definitions of biomaterials for the twenty—first century. Elsevier; 2019. p. 55-101.
[215]

Chagri S, Ng DYW, Weil T . Designing bioresponsive nanomaterials for intracellular self—assembly. Nat Rev Chem 2022; 6(5):320-38.
[216]

Zhang W, Gao X, Zhang H, Sun G, Zhang G, Li X, et al. Maglev—fabricated long and biodegradable stent for interventional treatment of peripheral vessels. Nat Commun 2024; 15(1):7903.
[217]

Tu Z, Zhong Y, Hu H, Shao D, Haag R, Schirner M, et al. Design of therapeutic biomaterials to control inflammation. Nat Rev Mater 2022;7(7):557-74.
[218]

Xu M, Lin Z, Tong X, Yang D, Shao Y . Biomaterial—based fibrous implantable probes for tissue—electronics interface. Adva Mater 2025; 37:2504372.
PDF (4285KB)

9

Accesses

0

Citation

Detail
Sections
Recommended

/

〈 〉